Skip to main content
Clinical Trials/NCT04589481
NCT04589481CompletedNot Applicable

Effectiveness of Different Candies Against Bad Breath

University Hospital, Basel, Switzerland2 sites in 1 country35 target enrollmentStarted: February 23, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
35
Locations
2
Primary Endpoint
Organoleptic analysis of breathing air sample

Study Overview

Brief Summary

This study is to analyze whether the candies can relieve or eliminate bad breath, both subjectively and objectively.

Detailed Description

This study is to systematically examine an existing candy, which is easily available and is intended to relieve or eliminate bad breath. The main aim of the study is to determine the effectiveness of the candies on the subjective perception of bad breath. The secondary outcome of the study is to investigate whether there is actually a decrease in volatile sulphur compounds (VSC) in the exhaled air and also a decrease in bad breath during organoleptic measurement.

The purpose of the study is to investigate whether the different candies can relieve or eliminate bad breath, both subjectively and objectively.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Non- smoker
  • No general medical illness or medication

Exclusion Criteria

  • Allergies/intolerances to ingredients of the products used
  • Chronic diseases
  • Pregnancy

Outcomes

Primary Outcomes

Organoleptic analysis of breathing air sample

Time Frame: max 60 minutes at 3 different days

Assessment of the patient's bad breath on the basis of the subjective assessment of an investigator (scale of 0 to 5 (0, no odor; 1, questionable odor; 2, slight malodor; 3, moderate malodor; 4, strong malodor; 5, severe malodor))

Measurement of volatile sulphur compounds (VSC) in ppb (parts per billion).

Time Frame: max 60 minutes at 3 different days

Assessment of the patient's bad breath on the basis of the objective assessment by a sulfide monitor (HaliSens® AI Analytical Innovations GmbH, Moosbach, Germany)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials